$2.3 Billion is the total value of Redmile Group, LLC's 76 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 21.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FOLD | Sell | AMICUS THERAPEUTICS INC | $203,466,688 | -17.7% | 18,346,861 | -9.4% | 8.83% | -12.7% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $153,177,197 | +1.9% | 1,913,280 | +0.9% | 6.65% | +8.1% |
| ISEE | Sell | IVERIC BIO INC | $102,312,662 | +6.1% | 4,205,206 | -6.6% | 4.44% | +12.6% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $86,243,522 | +46.4% | 5,582,105 | +55.3% | 3.74% | +55.3% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $78,218,323 | -45.8% | 2,044,389 | -22.4% | 3.39% | -42.5% |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $77,822,237 | +3.8% | 2,925,648 | -24.6% | 3.38% | +10.1% |
| FATE | FATE THERAPEUTICS INC | $73,856,165 | -43.5% | 12,957,222 | 0.0% | 3.20% | -40.1% | |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $71,431,085 | +7.0% | 2,410,769 | -9.8% | 3.10% | +13.5% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $67,633,009 | -23.3% | 1,879,739 | -4.9% | 2.94% | -18.6% |
| REPL | Sell | REPLIMUNE GROUP INC | $67,319,708 | -48.8% | 3,811,988 | -21.1% | 2.92% | -45.7% |
| Sell | ZYMEWORKS INC | $54,853,979 | +13.0% | 6,067,918 | -1.7% | 2.38% | +19.8% | |
| PEN | Sell | PENUMBRA INC | $52,391,490 | +6.2% | 187,992 | -15.2% | 2.27% | +12.6% |
| LIVN | Buy | LIVANOVA PLC | $51,704,096 | -15.9% | 1,186,418 | +7.2% | 2.24% | -10.8% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $49,362,318 | -28.7% | 1,612,094 | -9.0% | 2.14% | -24.4% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $49,043,816 | -3.5% | 335,159 | +5.1% | 2.13% | +2.4% |
| ARGX | Sell | ARGENX SEsponsored adr | $48,636,593 | -13.6% | 130,540 | -12.1% | 2.11% | -8.3% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $47,451,527 | -49.0% | 1,325,832 | -43.8% | 2.06% | -45.9% |
| IGMS | IGM BIOSCIENCES INC | $45,814,038 | -19.2% | 3,334,355 | 0.0% | 1.99% | -14.3% | |
| OSH | Sell | OAK STR HEALTH INC | $41,050,891 | +34.3% | 1,061,295 | -25.3% | 1.78% | +42.5% |
| CTLT | New | CATALENT INC | $40,103,076 | – | 610,304 | +100.0% | 1.74% | – |
| DXCM | New | DEXCOM INC | $39,042,057 | – | 336,048 | +100.0% | 1.69% | – |
| SYK | Buy | STRYKER CORPORATION | $38,956,378 | +50.5% | 136,464 | +28.9% | 1.69% | +59.6% |
| STOK | Buy | STOKE THERAPEUTICS INC | $34,531,149 | +482.3% | 4,145,396 | +545.3% | 1.50% | +516.5% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $32,591,931 | – | 335,170 | +100.0% | 1.41% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $31,920,739 | – | 231,595 | +100.0% | 1.38% | – |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $31,150,825 | – | 449,442 | +100.0% | 1.35% | – |
| RGNX | Sell | REGENXBIO INC | $31,026,110 | -28.5% | 1,640,725 | -14.3% | 1.35% | -24.2% |
| IMGN | Sell | IMMUNOGEN INC | $30,897,473 | -27.0% | 8,046,217 | -5.7% | 1.34% | -22.5% |
| ANTM | Buy | ELEVANCE HEALTH INC | $30,530,464 | +52.7% | 66,398 | +70.4% | 1.32% | +62.0% |
| Sell | VENTYX BIOSCIENCES INC | $27,328,429 | -6.9% | 815,774 | -8.8% | 1.19% | -1.2% | |
| Sell | ENTRADA THERAPEUTICS INC | $26,558,316 | +5.9% | 1,831,608 | -1.2% | 1.15% | +12.4% | |
| ADCT | Buy | ADC THERAPEUTICS SA | $26,452,236 | -9.3% | 13,565,249 | +78.7% | 1.15% | -3.7% |
| HUM | New | HUMANA INC | $25,282,271 | – | 52,079 | +100.0% | 1.10% | – |
| AUGX | AUGMEDIX INC | $25,021,769 | +11.5% | 14,380,327 | 0.0% | 1.09% | +18.3% | |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $24,993,808 | +31.8% | 3,124,226 | +49.1% | 1.08% | +39.7% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $24,925,212 | -36.9% | 2,533,050 | -5.6% | 1.08% | -33.1% |
| Sell | PRIME MEDICINE INC | $24,511,969 | -40.3% | 1,992,843 | -9.8% | 1.06% | -36.6% | |
| NRIX | Sell | NURIX THERAPEUTICS INC | $24,414,530 | -25.9% | 2,749,384 | -8.4% | 1.06% | -21.4% |
| Sell | STEVANATO GROUP S P A | $23,360,039 | +37.9% | 901,932 | -4.3% | 1.01% | +46.3% | |
| CRL | New | CHARLES RIV LABS INTL INC | $23,275,497 | – | 115,328 | +100.0% | 1.01% | – |
| IMVT | Buy | IMMUNOVANT INC | $20,427,151 | +5.8% | 1,317,031 | +21.0% | 0.89% | +12.2% |
| GRTS | Sell | GRITSTONE BIO INC | $19,256,854 | -19.5% | 6,926,926 | -0.1% | 0.84% | -14.5% |
| CNC | Sell | CENTENE CORP DEL | $17,531,357 | -24.0% | 277,351 | -1.4% | 0.76% | -19.4% |
| STTK | SHATTUCK LABS INC | $16,522,547 | +27.8% | 5,619,914 | 0.0% | 0.72% | +35.5% | |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $16,274,962 | -20.5% | 5,612,056 | -10.1% | 0.71% | -15.8% |
| VERV | Sell | VERVE THERAPEUTICS INC | $16,160,191 | -31.7% | 1,120,679 | -8.3% | 0.70% | -27.5% |
| IQV | New | IQVIA HLDGS INC | $14,251,861 | – | 71,657 | +100.0% | 0.62% | – |
| ABSCI CORPORATION | $14,054,415 | -16.7% | 8,031,094 | 0.0% | 0.61% | -11.6% | ||
| ETNB | New | 89BIO INC | $13,707,000 | – | 900,000 | +100.0% | 0.60% | – |
| ANNX | ANNEXON INC | $13,487,282 | -25.5% | 3,503,190 | 0.0% | 0.58% | -21.1% | |
| RAPT | Sell | RAPT THERAPEUTICS INC | $12,627,222 | -18.7% | 688,132 | -12.3% | 0.55% | -13.8% |
| ALLK | Sell | ALLAKOS INC | $10,173,488 | -52.5% | 2,286,177 | -10.2% | 0.44% | -49.7% |
| MDVL | MEDAVAIL HOLDINGS INC | $9,917,654 | -4.4% | 34,604,516 | 0.0% | 0.43% | +1.4% | |
| BSX | New | BOSTON SCIENTIFIC CORP | $8,594,153 | – | 171,780 | +100.0% | 0.37% | – |
| ILMN | New | ILLUMINA INC | $7,789,495 | – | 33,496 | +100.0% | 0.34% | – |
| ALVR | ALLOVIR INC | $7,517,398 | -23.2% | 1,907,969 | 0.0% | 0.33% | -18.5% | |
| SCIENCE 37 HOLDINGS INC | $5,577,999 | -32.2% | 19,808,234 | 0.0% | 0.24% | -28.0% | ||
| GRFS | Buy | GRIFOLS S Asp adr rep b nvt | $5,312,178 | +91.9% | 720,784 | +121.4% | 0.23% | +103.5% |
| NUVB | NUVATION BIO INC | $5,031,475 | -13.5% | 3,031,009 | 0.0% | 0.22% | -8.4% | |
| Buy | SOMALOGIC INC | $4,770,639 | +26.7% | 1,870,839 | +24.7% | 0.21% | +34.4% | |
| LVTX | Sell | LAVA THERAPEUTICS NV | $3,443,458 | -65.1% | 2,074,372 | -26.3% | 0.15% | -63.0% |
| NVTA | INVITAE CORP | $3,078,544 | -27.4% | 2,280,403 | 0.0% | 0.13% | -23.0% | |
| STXS | STEREOTAXIS INC | $3,034,490 | -1.4% | 1,487,495 | 0.0% | 0.13% | +4.8% | |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $2,653,136 | -61.2% | 586,977 | -3.4% | 0.12% | -58.9% |
| CABA | Sell | CABALETTA BIO INC | $2,268,064 | -47.2% | 274,252 | -40.9% | 0.10% | -44.3% |
| HOOK | Sell | HOOKIPA PHARMA INC | $1,878,970 | -25.5% | 2,552,949 | -18.0% | 0.08% | -20.4% |
| INVIVYD INC | $1,728,870 | -20.0% | 1,440,725 | 0.0% | 0.08% | -14.8% | ||
| XERIS BIOPHARMA HOLDINGS INC | $1,705,937 | +22.6% | 1,046,587 | 0.0% | 0.07% | +29.8% | ||
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $1,539,745 | +6.4% | 1,608,089 | 0.0% | 0.07% | +13.6% | |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $1,293,320 | +37.3% | 1,847,600 | -0.2% | 0.06% | +43.6% |
| TKNO | Sell | ALPHA TEKNOVA INC | $1,104,802 | -64.9% | 373,244 | -33.1% | 0.05% | -62.8% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $987,504 | +35.2% | 658,336 | -10.0% | 0.04% | +43.3% |
| SONENDO INC | $996,262 | -29.3% | 498,131 | 0.0% | 0.04% | -25.9% | ||
| CTSO | Sell | CYTOSORBENTS CORP | $612,123 | +48.3% | 181,639 | -31.8% | 0.03% | +58.8% |
| BCEL | ATRECA INC | $504,624 | +42.4% | 442,653 | 0.0% | 0.02% | +57.1% | |
| Sell | THE ONCOLOGY INSTITUTE INC | $215,628 | -91.7% | 318,082 | -79.9% | 0.01% | -91.6% | |
| BVS | Exit | BIOVENTUS INC | $0 | – | -535,950 | -100.0% | -0.06% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -266,187 | -100.0% | -0.41% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -625,000 | -100.0% | -0.61% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -2,326,625 | -100.0% | -1.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.